• Tue, April 4, 2023
Ken Cacciatore Maintained (TAK) at Buy with Increased Target to $30 on, Apr 4th, 2023
Ken Cacciatore of TD Cowen, Maintained "Takeda Pharmaceutical Company Limited" (TAK) at Buy with Increased Target from $24 to $30 on, Apr 4th, 2023.
Ken has made no other calls on TAK in the last 4 months.
There is 1 other peer that has a rating on TAK. Out of the 1 peers that are also analyzing TAK, 0 agree with Ken's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ken
- Koichi Mamegano of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $20 on, Thursday, March 16th, 2023
Like: 👍
